Physician profile
John A Waters
NPI 1396706925
$884.64
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2021: $170 · 2022: $71.56 · 2023: $61.27 · 2024: $185 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $125.93 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $113.18 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $72.08 | 2019 | |
| Bausch & Lomb Americas INC. | $70.47 | 2025 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $63.00 | 2024 | Xdemvy |
| Dompe US, INC. | $58.65 | 2021 | |
| Harrow Eye, LLC | $58.58 | 2025 | Iheezo, Vevye |
| Allergan, INC. | $50.52 | 2019-2021 | |
| Abbvie INC. | $49.37 | 2023-2025 | Xen Glaucoma Treatment System |
| New World Medical,INC. | $49.16 | 2021-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Carl Zeiss Meditec, INC. | $36.11 | 2024 | |
| Biotissue Holdings INC. | $35.01 | 2024 | |
| Amgen INC. | $30.44 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $25.57 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $19.24 | 2023 | Tecnis Iol |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.57 | 2019 | |
| Mallinckrodt Hospital Products INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.